CompletedNot Applicable

Bisphosphonate-Associated Jaw Osteonecrosis and PET Imaging

United States25 participantsStarted 2006-10

Plain-language summary

1. Bisphosphonate-associated osteonecrosis of the jaw(ONJ)is detectable by positron emission tomography(PET). 2. Bisphosphonate-associated ONJ can be diagnosed and characteristically differentiated from other bony pathologies of the jaw(osteomyelitis, osteolytic lesions, and osteoradionecrosis)by PET imaging.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of bisphosphonate-associated ONJ, osteomyelitis, osteoradionecrosis,and osteolytic lesions who received PET imaging at presentation Exclusion Criteria: * Anyone who has not been diagnosed with bisphosphonate-associated ONJ, osteomyelitis, osteoradionecrosis,or osteolytic lesions who received PET imaging at presentation

Trial details

NCT IDNCT00592982

SponsorUniversity of Arkansas

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2013-08

View on ClinicalTrials.gov More Bisphosphonate-associated ONJ trials